Latest News

  • Triple-Negative Breast Cancer Study Reveals Multiple Findings

    A clinical trial study led by Priyanka Sharma, MD, breast oncologist at The University of Kansas Cancer Center, demonstrates that triple-negative breast cancer patients fare better when treated with a common adjuvant chemotherapy combination.

  • Exosomes Possible Biomarker for Targeted Sarcoma Therapy

    Researchers at The University of Kansas Cancer Center are studying tiny vesicles that may help lead to more targeted cancer therapies. Also called exosomes, these microvesicles act as “fingerprints” of a tumor’s identity, providing early clues to cancer cases.

  • First Patient Dosed with Ciclopirox Prodrug in Phase I Trial in Patients with Advanced Solid Tumors

    CicloMed LLC, a biotechnology company developing novel treatments for bladder cancer, announced that the first patient has been dosed in a Phase I clinical trial. The anti-cancer drug, called Ciclopirox Prodrug, or CPX-POM, was discovered at The University of Kansas Cancer Center. The study is characterizing the safety, dose tolerance, pharmacokinetics and pharmacodynamics in patients with advanced solid tumors.

View All


Browse by Year
2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Expert Care

find a doctor

Named Among US News & World Reports Best Hospitals for Cancer care 2017-18

Request an Appointment